e-Therapeutics (LSE:ETX) YoY EPS Growth : -42.86% (As of Jul. 2023)

View and export this data going back to 2007. Start your Free Trial

What is e-Therapeutics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. e-Therapeutics's YoY EPS Growth for the quarter that ended in Jul. 2023 was -42.86%.

e-Therapeutics's Earnings per Share (Diluted) for the six months ended in Jul. 2023 was £-0.01.

e-Therapeutics YoY EPS Growth Historical Data

The historical data trend for e-Therapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

e-Therapeutics YoY EPS Growth Chart

e-Therapeutics Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

YoY EPS Growth

Get a 7-Day Free Trial

25.00

40.00

-11.11

-70.00

11.76

e-Therapeutics Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
YoY EPS Growth	Get a 7-Day Free Trial															16.67	-175.00	-40.00	27.27	-42.86

e-Therapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

e-Therapeutics's YoY EPS Growth for the fiscal year that ended in Jan. 2023 is calculated as:

	YoY EPS Growth (A: Jan. 2023 )
=	(Earnings per Share (Diluted) (A: Jan. 2023 )	-	Earnings per Share (Diluted) (A: Jan. 2022 ))	/	\| Earnings per Share (Diluted) (A: Jan. 2022 ) \|
=	(-0.015	-	-0.017)	/	\| -0.017 \|
=	11.76 %

e-Therapeutics's YoY EPS Growth for the quarter that ended in Jul. 2023 is calculated as:

	YoY EPS Growth (Q: Jul. 2023 )
=	(Earnings per Share (Diluted) (Q: Jul. 2023 )	-	Earnings per Share (Diluted) (Q: Jul. 2022 ))	/	\| Earnings per Share (Diluted) (Q: Jul. 2022 )) \|
=	(-0.01	-	-0.007)	/	\| -0.007 \|
=	-42.86 %

e-Therapeutics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of e-Therapeutics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

e-Therapeutics (LSE:ETX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » e-Therapeutics PLC (LSE:ETX) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

ETXPF:USA

Address

4 Kingdom Street, Paddington, London, GBR, W2 6BD

Website

https://www.etherapeutics.co.uk

e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.

e-Therapeutics (LSE:ETX) Headlines

From GuruFocus

Eaton Vance Municipal Income 2028 Term Trust Announces Telephonic Annual Meeting Of Shareholders On November 12, 2021

By PRNewswire PRNewswire • 11-02-2021